PlainPharmaWatch

CMS Open Payments · Tool

Regeneron Healthcare Solutions, Inc. vs Grace Medical, Inc.

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Grace Medical, Inc. has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 3,285, versus 19 for the other company. Its single largest recorded recipient represents 0.5% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

Regeneron Healthcare Solutions, Inc.
HHI 19 · top recipient 0.0%
Ranked #1,817 of 1,838 companies by HHI
Grace Medical, Inc.
HHI 3,285 · top recipient 0.5%
Ranked #534 of 1,838 companies by HHI

Payment Overview

Total Payments
$24.7M
% of Industry
0.2%
Transactions
169,362
Avg per Transaction
$146.04
Recipients
169,362
Avg per Recipient
$146.04
Payment Types
6
Top Payment Type
Compensation for Services Other Than Consulting
Total Payments
$24.1M
% of Industry
0.2%
Transactions
54
Avg per Transaction
$447.0K
Recipients
51
Avg per Recipient
$473.3K
Payment Types
2
Top Payment Type
Royalty or License

Highlighted values indicate the higher figure for each metric.

Total payments compared

Regeneron Healthcare Solutions, Inc. vs Grace Medical, Inc. - total reported payments in CMS Open Payments PY2024

Regeneron Healthcare Soluti…$24.7MGrace Medical, Inc.$24.1M

Payment Types Breakdown

Regeneron Healthcare Solutions, Inc.

Compensation for Services Other Than Consulting $15.5M

62.6%

Food and Beverage $4.5M

18.1%

Travel and Lodging $2.0M

7.9%

Consulting Fee $1.9M

7.7%

Grant $699.5K

2.8%

Education $230.9K

0.9%

Grace Medical, Inc.

Royalty or License $43.2K

0.2%

Food and Beverage $3.6K

0.0%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

Regeneron Healthcare Solutions, Inc.

  1. 1

    MAYO CLINIC HOSPITAL

    $197,420.00 · 9 txns

  2. 2

    GREGORY WILLIAM BENSCH

    $128,884.00 · 113 txns

  3. 3

    MICHAEL JAVAHERI

    $128,542.03 · 106 txns

  4. 4

    MARC J SEROTA

    $126,322.04 · 165 txns

  5. 5

    TODD SCHLESINGER

    $122,890.00 · 110 txns

Grace Medical, Inc.

  1. 1

    SAMUEL LEVINE

    $24,763.48 · 4 txns

  2. 2

    ERIC KRAUS

    $8,150.34 · 4 txns

  3. 3

    DENNIS BOJRAB

    $4,520.59 · 4 txns

  4. 4

    ALEJANDRO RIVAS CAMPO

    $3,985.08 · 5 txns

  5. 5

    DOUGLAS BACKOUS

    $1,889.58 · 5 txns

Summary Comparison

Metric Regeneron Healthcare Solutions, Inc. Grace Medical, Inc.
Total Payments $24.7M $24.1M
% of Industry Total 0.2% 0.2%
Transaction Count 169,362 54
Avg per Transaction $146.04 $447.0K
Recipient Count 169,362 51
Avg per Recipient $146.04 $473.3K
Payment Type Count 6 2
Top Payment Type Compensation for Services Other Than Consulting Royalty or License

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.